Results 41 to 50 of about 28,733 (232)
Background: Transcatheter aortic valve replacement (TAVR) has determined a paradigm shift in the treatment of patients with severe aortic stenosis. However, the durability of bioprostheses is still a matter of concern, and little is known about the management of degenerated TAV.
Luca Testa +38 more
openaire +5 more sources
Transcatheter Aortic Valve Replacement on an Aortic Mechanical Valve
A 71-year-old woman with a history of rheumatic heart valve disease and prior aortic and mitral mechanical valve replacement (Carbomedics #21 and #29, CarboMedics Inc., Austin, Texas, respectively), was referred for transcatheter closure of a mitral perivalvular leak due to New York ...
Dabit, Arzamendi +5 more
openaire +2 more sources
Objective: We examined the effect of frailty on in-hospital mortality, readmission rates, and hospitalization costs after transcatheter and surgical aortic valve replacement in a population-level cohort.
Travis J. Miles, MD +9 more
doaj +1 more source
Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era
After the success and worldwide adoption of transcatheter aortic valve replacement (TAVR), the percutaneous replacement of a diseased mitral valve (MV) rapidly became a target for investigators and industry. The rejuvenated enthusiasm of industry in this field is also corroborated by the fact that, in 2015, ≈2.5 billion dollars were invested in MV ...
Luca Testa +5 more
openaire +4 more sources
Background: Transcatheter treatments of tricuspid regurgitation (TR) have been emerging as alternatives for high-risk patients. In contrast to the immobilization of the common transcatheter tricuspid device, using a radial force-independent stent valve ...
Mengen Zhai +4 more
doaj +1 more source
CT in Transcatheter Aortic Valve Replacement [PDF]
Transcatheter aortic valve replacement is a new method to treat patients with symptomatic, severe aortic stenosis who are at high surgical risk. Short- and midterm results have been encouraging, with more than 90,000 procedures performed worldwide. Patient selection, prosthesis sizing, and access strategies heavily rely on noninvasive imaging. Computed
Philipp, Blanke +2 more
openaire +2 more sources
Background Acute kidney injury after cardiac surgery significantly associates with morbidity and mortality. Despite not requiring cardiopulmonary bypass, transcatheter aortic valve replacement patients have an incidence of post-procedural acute kidney ...
Akeel M. Merchant +9 more
doaj +1 more source
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. [PDF]
AIMS Owing to new evidence from randomized controlled trials (RCTs) in low-risk patients with severe aortic stenosis, we compared the collective safety and efficacy of transcatheter aortic valve implantation (TAVI) vs.
Salanti, Georgia +15 more
core +1 more source
Updates on transcatheter aortic valve replacement: Techniques, complications, outcome, and prognosis
Transcatheter aortic valve replacement (TAVR) initially emerged as a therapeutic option for high-risk patients with severe aortic stenosis. Advancement in technologies since the first era of TAVRs, experience from previous obstacles, and lessons learned ...
Jarrah Alfadhli +3 more
doaj +1 more source
Transcatheter Aortic Valve Replacement in Patients With Multivalvular Heart Disease.
As transcatheter aortic valve replacement becomes a more dominant treatment option across all risk profiles, the frequency of encountering patients with multivalvular disease will increase.
Lanz, Jonas +7 more
core +1 more source

